Latest hum. ProductsDetails
Product Name in the RMS: Certican
MR Number: SE/H/0356/006
Date of outcome: 02.12.2003
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
New Active Substance Additional Strength/Form Full Dossier Chemical Substance Prescription Only |
| Active Substances |
everolimus 0,25 mg |
| Form | Dispersible tablet |
| MA Holder in the RMS |
Novartis Sverige AB Sweden |
| RMS | Sweden |
| Date of last change | 04.02.2021 |
| ATC-Code |
L04AA18 Everolimus |
| CMS Country | Domestic Product Name |
|---|---|
| Austria | Certican 0,25 mg - Tabletten zur Herstellung einer Suspension zum Einnehmen |
| Belgium | |
| Bulgaria | Certican |
| Denmark | |
| Finland | |
| France | |
| Germany | |
| Greece | |
| Hungary | |
| Iceland | |
| Ireland | |
| Italy | |
| Lithuania | Certican 0,25mg disperguojamosios tabletės |
| Luxembourg | |
| Malta | |
| Netherlands | |
| Norway | |
| Poland | |
| Portugal | |
| Romania | CERTICAN 0,25 mg comprimate pentru dispersie orală |
| Slovak Republic | |
| Slovenia | |
| Spain | Certicam 0.25 mg comprimidos dispersables |
| United Kingdom |
| Documents | |
|---|---|
| PAR: | http://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000430 (10.12.2014) |
| PARSummary: | http://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000461 (09.01.2015) |
| FinalSPC: | https://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000461 (15.01.2014) |
| FinalPL: | https://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000461 (15.01.2014) |
